Additionally, these findings align with previous RNA interference reports demonstrating that BCL-xL but not BCL-2 is necessary for the survival of senescent HUVECs [15] and senescent DOX-treated cancer cells [50]. This evidence concerns the gene BCL2L1 and cancer.